Skip to main content
. 2021 Jul 15;6(10):2565–2574. doi: 10.1016/j.ekir.2021.07.008

Table 1.

Baseline characteristics

COVID-19 (n = 1091) Influenza (n = 1334)
Age (yr) 67 (18) 71 (16)
Sex, male, n (%) 540 (50) 599 (45)
Baseline creatinine, mean (SD) 1.02 (0.41) 1.06 (0.44)
Baseline eGFR (mean (SD)) 75.9 (27.7) 69.6 (26.2)
eGFR stages (n (%)
 eGFR ≥60 760 (70) 811 (61)
 eGFR 45–59.9 160 (15) 263 (20)
 eGFR 30–44.9 123 (11) 180 (13)
 eGFR 15–29.9 48 (4) 80 (6)
Race/ethnicity, n (%)
 White, non-Hispanic 578 (53) 1018 (76)
 White, Hispanic 244 (22) 100 (8)
 Blacka 184 (17) 119 (9)
 Other/unknown 85 (8) 97 (9)
Comorbidities, n (%)
 Hypertension 839 (77) 1136 (85)
 Diabetes mellitus 549 (50) 602 (45)
 Coronary artery disease 443 (41) 783 (59)
 Chronic obstructive pulmonary disease 175 (16) 528 (40)
 Congestive heart failure 113 (10) 271 (20)
 Cirrhosis 53 (5) 80 (6)
 Human immunodeficiency virus 24 (2) 32 (2)
Medications, n (%)
 ACEi/ARBs 397 (36) 535 (40)
 Loop diuretics 280 (26) 467 (35)
 Thiazide diuretics 162 (15) 198 (15)
 K-sparing diuretics 63 (6) 116 (9)
 Proton pump inhibitors 381 (35) 615 (46)
 Nonsteroidal anti-inflammatory drugs 371 (34) 425 (32)
 Immunosuppressants 185 (17) 521 (39)
Baseline laboratory values, median (IQR)
 Hemoglobin, g/dl 12.5 (11.2–13.8) 12.3 (10.8–13.6)
 White blood cell count, K/μl 7.35 (5.91–9.32) 7.55 (5.87–9.62)
 Sodium, mmol/l 140 (138–142) 140 (138–142)
 Platelets, K/μl 227 (184–278) 219 (174–279)
 Albumin, g/dl 4.1 (3.7–4.4) 4.0 (3.6–4.3)

ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; eGFR, estimated glomerular filtration rate; IQR, interquartile range.

Missing data: hemoglobin (COVID-19 = 127 [12%], influenza = 86 [7%]), white blood cells (COVID-19 = 128 [12%], influenza = 88 [7%]), sodium (COVID-19 = 20 [2%], influenza = 14 [1%]), platelets (COVID-19 = 130 [12%], influenza = 88 [7%]), and albumin (COVID-19 = 275 [25%], influenza = 287 [22%]).

a

Individuals who were listed as both Black and Hispanic were classified as Black for the purposes of our analyses.